Lund University, Department of Clinical Sciences Lund, Radiology, Lund, Sweden.
Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Oncology and Pathology, Lund, Sweden.
Neuroimage. 2018 Nov 15;182:232-250. doi: 10.1016/j.neuroimage.2018.04.075. Epub 2018 May 8.
Imaging is an indispensable tool for brain tumour diagnosis, surgical planning, and follow-up. Definite diagnosis, however, often demands histopathological analysis of microscopic features of tissue samples, which have to be obtained by invasive means. A non-invasive alternative may be to probe corresponding microscopic tissue characteristics by MRI, or so called 'microstructure imaging'. The promise of microstructure imaging is one of 'virtual biopsy' with the goal to offset the need for invasive procedures in favour of imaging that can guide pre-surgical planning and can be repeated longitudinally to monitor and predict treatment response. The exploration of such methods is motivated by the striking link between parameters from MRI and tumour histology, for example the correlation between the apparent diffusion coefficient and cellularity. Recent microstructure imaging techniques probe even more subtle and specific features, providing parameters associated to cell shape, size, permeability, and volume distributions. However, the range of scenarios in which these techniques provide reliable imaging biomarkers that can be used to test medical hypotheses or support clinical decisions is yet unknown. Accurate microstructure imaging may moreover require acquisitions that go beyond conventional data acquisition strategies. This review covers a wide range of candidate microstructure imaging methods based on diffusion MRI and relaxometry, and explores advantages, challenges, and potential pitfalls in brain tumour microstructure imaging.
成像技术是脑肿瘤诊断、手术规划和随访的不可或缺的工具。然而,明确的诊断通常需要对组织样本的微观特征进行组织病理学分析,而这必须通过有创手段获得。一种非侵入性的替代方法可能是通过 MRI 探测相应的微观组织特征,即所谓的“微观结构成像”。微观结构成像的前景是“虚拟活检”,其目标是用成像替代有创操作,以指导术前规划,并可进行纵向重复以监测和预测治疗反应。这种方法的探索是由 MRI 与肿瘤组织学之间的显著关联所驱动的,例如表观扩散系数与细胞密度之间的相关性。最近的微观结构成像技术探测到了更细微和更特异的特征,提供了与细胞形状、大小、渗透性和体积分布相关的参数。然而,这些技术在哪些情况下能提供可靠的成像生物标志物,用于检验医学假说或支持临床决策,目前仍不清楚。精确的微观结构成像可能需要超越传统数据采集策略的采集。这篇综述涵盖了基于扩散 MRI 和弛豫测量的广泛的候选微观结构成像方法,并探讨了脑肿瘤微观结构成像的优势、挑战和潜在问题。